uniQure director David D. Meek sells 9,080 shares

Available on EDGAR 11/10/2026 - 04:05 PM EST Accepted by SEC EDGAR 11/10/2026 - 04:04 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

uniQure N.V. director David D. Meek sold 9,080 ordinary shares on November 6, 2026, at $21.25 per share. His reported direct holding after the sale was 30,667 shares. The sale was made pursuant to a sales plan adopted May 26, 2026, intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

Insider Trade Summary 10b5-1

Net Seller: 9,080 shares

Net Sell 1 txn

Insider Meek David D.

Role Director

Sold 9,080 shs ($193K)

Share of Position Sold 22.8%

Type	Security	Shares	Price	Value
Sale	Ordinary Shares F1	9,080	$21.25	$193K

Holdings After Transaction: Ordinary Shares — 30,667 shares (Direct)

Holdings Before and After: Ordinary Shares, 39,747 to 30,667 shares (Direct)

Footnotes (1)

1. F1. The shares were sold pursuant to a sales plan adopted by the Reporting Person on May 26, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

Key Figures

Ordinary shares sold: 9,080 shares Sale price: $21.25 per share Direct shares held after sale: 30,667 shares

3 metrics

Ordinary shares sold 9,080 shares November 6, 2026

Sale price $21.25 per share November 6, 2026

Direct shares held after sale 30,667 shares After the November 6, 2026 sale

Key Terms

Rule 10b5-1, sales plan, Ordinary Shares

3 terms

Rule 10b5-1 regulatory

"intended to comply with Rule 10b5-1"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

sales plan financial

"sold pursuant to a sales plan"

Ordinary Shares financial

"Security title: Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many QURE shares did David D. Meek sell, and at what price?

David D. Meek sold 9,080 ordinary shares at $21.25 per share on November 6, 2026. The sale was made pursuant to a sales plan adopted May 26, 2026, intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Meek David D.

(Last) (First) (Middle)

C/O UNIQURE N.V.

PAASHEUVELWEG 25A

(Street)

AMSTERDAM 1105BP

(City) (State) (Zip)

NETHERLANDS

(Country)

2. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	11/06/2026		S(1)		9,080	D	$21.25	30,667	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold pursuant to a sales plan adopted by the Reporting Person on May 26, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

	/s/ Christian Klemt, Attorney-in-Fact	11/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)